Drug Profile
Yellow fever vaccine - Evans Vaccines
Alternative Names: ArilvaxLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Evans Vaccines
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Yellow fever
Most Recent Events
- 20 Apr 2006 Chiron Corporation has been acquired and merged into Novartis
- 19 Feb 2004 Suspended - Preregistration for Yellow fever in USA (SC)
- 16 Dec 2003 Preregistration for Yellow fever in USA (SC)